http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2713197-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e079aad8c03b57871b2bb3f1142a9da |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 |
filingDate | 2019-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05979c81cdc3aab93000e2c77be1217c |
publicationDate | 2020-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2713197-C1 |
titleOfInvention | Pharmaceutical ethambutol composition |
abstract | FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to a pharmaceutical ethambutol composition presented in the form of a tablet containing an active substance and a combination of excipients having the following composition in g/100 g: ethambutol hydrochloride – 55.55–83.33; lactose monohydrate – 35.44–7.6; sodium carboxymethyl starch – 4; gelatine – 2.5; magnesium stearate – 1.5; colloidal silicon dioxide – 1.EFFECT: invention provides preparing ethambutol pharmaceutical compositions containing 100, 200, 400, 600, 800, 1000 mg of the active substance, presented in the form of tablets which are easy to use, differing by the absence of carcinogenic substances in their composition.1 cl, 3 dwg, 7 tbl |
priorityDate | 2019-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.